Biological-Activity-Based Prioritization of Antidepressants in Wastewater in England and Japan.

Antidepressants are one of the most commonly prescribed pharmaceuticals. Although they have been frequently detected in aquatic environments around the globe, little is known regarding their adverse effects on humans and aquatic organisms. Recently, an in vitro monoamine transporter inhibition assay was developed to detect transporter-inhibitory activities of antidepressants in wastewater in Japan. However, it was unclear which antidepressants were responsible for transporter-inhibitory activities in wastewater. Herein, the per capita consumption of 32 antidepressants, their excretion of unchanged parent compounds, per capita water consumption, removal rate during wastewater treatment processes, and potency values from the monoamine transporter inhibition assay were used to prioritize antidepressants of concern in effluent wastewater in England and Japan. In both countries, sertraline and O-desmethylvenlafaxine had the highest contribution to inhibitory activities against the human serotonin transporter (hSERT) and zebrafish SERT (zSERT), respectively. It was found that the antidepressants inhibited the zSERT more strongly than the hSERT. The inhibitory activities found against the zSERT in wastewater in England and Japan were higher than thresholds for abnormal behavior in fish. The antidepressants prioritized in this study provide insight into launching environmental monitoring and ecotoxicological studies of antidepressants.

[1]  A. Boxall,et al.  Assessment of the Potential Ecotoxicological Effects of Pharmaceuticals in the World's Rivers , 2022, Environmental toxicology and chemistry.

[2]  J. Sumpter,et al.  Environmental Occurrence and Predicted Pharmacological Risk to Freshwater Fish of over 200 Neuroactive Pharmaceuticals in Widespread Use , 2022, Toxics.

[3]  Salem S. Gharbia,et al.  Pharmaceutical pollution of the world’s rivers , 2022, Proceedings of the National Academy of Sciences.

[4]  Xiangru Zhang,et al.  Which Micropollutants in Water Environments Deserve More Attention Globally? , 2021, Environmental science & technology.

[5]  C. Tyler,et al.  The potential for adverse effects in fish exposed to antidepressants in the aquatic environment. , 2021, Environmental science & technology.

[6]  M. J. den Broeder,et al.  Interspecies Differences in Activation of Peroxisome Proliferator-Activated Receptor γ by Pharmaceutical and Environmental Chemicals. , 2021, Environmental science & technology.

[7]  W. Bourguet,et al.  A Comparative Study of Human and Zebrafish Pregnane X Receptor Activities of Pesticides and Steroids Using In Vitro Reporter Gene Assays , 2021, Frontiers in Endocrinology.

[8]  Hiroaki Tanaka,et al.  Proposal for fluorescence-based in vitro assay using human and zebrafish monoamine transporters to detect biological activities of antidepressants in wastewater. , 2021, The Science of the total environment.

[9]  M. V. van Driel,et al.  Antidepressant use in Australia and Sweden—A cross‐country comparison , 2020, Pharmacoepidemiology and drug safety.

[10]  Yingchao Lin,et al.  Evaluation of pharmaceutical activities of G-protein coupled receptor targeted pharmaceuticals in Chinese wastewater effluent , 2020 .

[11]  W. Bourguet,et al.  Human and zebrafish nuclear progesterone receptors are differently activated by manifold progestins. , 2020, Environmental science & technology.

[12]  Topi K. Lehtonen,et al.  Long-Term Pharmaceutical Contamination and Temperature Stress Disrupt Fish Behavior. , 2020, Environmental science & technology.

[13]  Caio Rodrigues-Silva,et al.  Tracking the occurrence of psychotropic pharmaceuticals in Brazilian wastewater treatment plants and surface water, with assessment of environmental risks. , 2020, The Science of the total environment.

[14]  Emma L. Schymanski,et al.  Tracking complex mixtures of chemicals in our changing environment , 2020, Science.

[15]  Hiroaki Tanaka,et al.  Biological-activity-based prioritization of pharmaceuticals in wastewater for environmental monitoring: G protein-coupled receptor inhibitors. , 2020, Environmental science & technology.

[16]  E. Kristiansson,et al.  Pharmacology beyond the patient - The environmental risks of human drugs. , 2019, Environment international.

[17]  S. Tanabe,et al.  Protecting the environment from psychoactive drugs: Problems for regulators illustrated by the possible effects of tramadol on fish behaviour. , 2019, The Science of the total environment.

[18]  S. R. Burket,et al.  Antidepressants in Surface Waters: Fluoxetine Influences Mosquitofish Anxiety-Related Behavior at Environmentally Relevant Levels. , 2019, Environmental science & technology.

[19]  N. Cristianini,et al.  Seasonal variation in antidepressant prescriptions, environmental light and web queries for seasonal affective disorder , 2019, British Journal of Psychiatry.

[20]  M. O’Bryan,et al.  Impact of the widespread pharmaceutical pollutant fluoxetine on behaviour and sperm traits in a freshwater fish. , 2019, The Science of the total environment.

[21]  A. Ragas,et al.  A High-Resolution Spatial Model to Predict Exposure to Pharmaceuticals in European Surface Waters: ePiE , 2018, Environmental science & technology.

[22]  Daniel L Villeneuve,et al.  Evidence for Cross Species Extrapolation of Mammalian-Based High-Throughput Screening Assay Results. , 2018, Environmental science & technology.

[23]  A. Johnson,et al.  Quantification of Pharmaceutical Related Biological Activity in Effluents from Wastewater Treatment Plants in UK and Japan. , 2018, Environmental science & technology.

[24]  C. Faggio,et al.  Effects of waterborne antidepressants on non-target animals living in the aquatic environment: A review. , 2018, The Science of the total environment.

[25]  D. Villeneuve,et al.  The advantages of linear concentration–response curves for in vitro bioassays with environmental samples , 2018, Environmental toxicology and chemistry.

[26]  J. Thomas-Oates,et al.  Temporal and spatial variation in pharmaceutical concentrations in an urban river system. , 2018, Water research.

[27]  Yonglong Lu,et al.  Which commonly monitored chemical contaminant in the Bohai region and the Yangtze and Pearl Rivers of China poses the greatest threat to aquatic wildlife? , 2018, Environmental toxicology and chemistry.

[28]  W. Brack,et al.  Solid-phase extraction as sample preparation of water samples for cell-based and other in vitro bioassays. , 2018, Environmental science. Processes & impacts.

[29]  Andrew C Johnson,et al.  An alternative approach to risk rank chemicals on the threat they pose to the aquatic environment. , 2017, The Science of the total environment.

[30]  Randolph R. Singh,et al.  Selective Uptake and Bioaccumulation of Antidepressants in Fish from Effluent-Impacted Niagara River. , 2017, Environmental science & technology.

[31]  Jiahua Guo,et al.  Toxicological and ecotoxicological risk‐based prioritization of pharmaceuticals in the natural environment , 2016, Environmental toxicology and chemistry.

[32]  Graham Young,et al.  Contaminants of emerging concern in a large temperate estuary. , 2016, Environmental pollution.

[33]  S. Snyder,et al.  Balancing the Budget: Accounting for Glucocorticoid Bioactivity and Fate during Water Treatment. , 2016, Environmental science & technology.

[34]  Martin Krauss,et al.  Linking in Vitro Effects and Detected Organic Micropollutants in Surface Water Using Mixture-Toxicity Modeling. , 2015, Environmental science & technology.

[35]  Calum A. MacRae,et al.  Zebrafish as tools for drug discovery , 2015, Nature Reviews Drug Discovery.

[36]  Hiroaki Tanaka,et al.  Evaluation of Estrogenic Activity of Wastewater: Comparison Among In Vitro ERα Reporter Gene Assay, In Vivo Vitellogenin Induction, and Chemical Analysis. , 2015, Environmental science & technology.

[37]  Marlene Ågerstrand,et al.  Improving environmental risk assessment of human pharmaceuticals. , 2015, Environmental science & technology.

[38]  B. Kasprzyk-Hordern,et al.  A review on emerging contaminants in wastewaters and the environment: current knowledge, understudied areas and recommendations for future monitoring. , 2015, Water research.

[39]  J. Aoki,et al.  Detection of physiological activities of G protein-coupled receptor-acting pharmaceuticals in wastewater. , 2015, Environmental science & technology.

[40]  L. Corominas,et al.  Occurrence and in-stream attenuation of wastewater-derived pharmaceuticals in Iberian rivers. , 2015, The Science of the total environment.

[41]  Marcus Östman,et al.  Occurrence and behaviour of 105 active pharmaceutical ingredients in sewage waters of a municipal sewer collection system. , 2014, Water research.

[42]  Vimal Kumar,et al.  Co-occurrence of estrogenic and antiestrogenic activities in wastewater: quantitative evaluation of balance by in vitro ERα reporter gene assay and chemical analysis. , 2014, Environmental science & technology.

[43]  J. Sumpter,et al.  The apparently very variable potency of the anti-depressant fluoxetine. , 2014, Aquatic toxicology.

[44]  J. Zhan,et al.  Growth inhibition and coordinated physiological regulation of zebrafish (Danio rerio) embryos upon sublethal exposure to antidepressant amitriptyline. , 2014, Aquatic toxicology.

[45]  D. Barceló,et al.  Determination of 81 pharmaceutical drugs by high performance liquid chromatography coupled to mass spectrometry with hybrid triple quadrupole-linear ion trap in different types of water in Serbia. , 2014, The Science of the total environment.

[46]  J. Fick,et al.  EU-wide monitoring survey on emerging polar organic contaminants in wastewater treatment plant effluents. , 2013, Water research.

[47]  Anton J. Enright,et al.  The zebrafish reference genome sequence and its relationship to the human genome , 2013, Nature.

[48]  David B. Senn,et al.  Prioritizing environmental risk of prescription pharmaceuticals. , 2013, Regulatory toxicology and pharmacology : RTP.

[49]  T. Furukawa,et al.  PMH9 Antidepressant Prescription Patterns Among Patients With Major Depression Based on Claims Database in Japan , 2012 .

[50]  Liliana J. G. Silva,et al.  Selective serotonin re-uptake inhibitors (SSRIs) in the aquatic environment: an ecopharmacovigilance approach. , 2012, The Science of the total environment.

[51]  W. Püttmann,et al.  Impact of wastewater treatment plant discharge of lidocaine, tramadol, venlafaxine and their metabolites on the quality of surface waters and groundwater. , 2012, Journal of environmental monitoring : JEM.

[52]  Rolf Altenburger,et al.  Using the fish plasma model for comparative hazard identification for pharmaceuticals in the environment by extrapolation from human therapeutic data. , 2011, Regulatory toxicology and pharmacology : RTP.

[53]  E. Furlong,et al.  Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows. , 2011, Aquatic toxicology.

[54]  H. Gardarsdottir,et al.  Seasonal patterns of initiating antidepressant therapy in general practice in the Netherlands during 2002-2007. , 2010, Journal of affective disorders.

[55]  M. Servos,et al.  Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed , 2010, Environmental toxicology and chemistry.

[56]  Christian G Daughton,et al.  Beyond the medicine cabinet: an analysis of where and why medications accumulate. , 2008, Environment international.

[57]  Kyungho Choi,et al.  Prioritizing veterinary pharmaceuticals for aquatic environment in Korea. , 2008, Environmental toxicology and pharmacology.

[58]  Erik Kristiansson,et al.  Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. , 2008, Environmental science & technology.

[59]  C. Gagnon,et al.  Determination of basic antidepressants and their N-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography-tandem mass spectrometry. , 2008, Analytical chemistry.

[60]  H. Galicia,et al.  Comparison of in vitro and in vivo estrogenic activity of UV filters in fish. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[61]  D. Geraghty,et al.  Differential effects of temperature and maturity stage on hepatic estrogen receptor characteristics of Atlantic salmon. , 2005, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[62]  N Voulvoulis,et al.  Pharmaceuticals in the aquatic environment--a comparison of risk assessment strategies. , 2004, Chemosphere.

[63]  A. D. Vethaak,et al.  Comparison of in vivo and in vitro reporter gene assays for short-term screening of estrogenic activity. , 2002, Environmental science & technology.

[64]  J. Hermens,et al.  Modes of action in ecotoxicology: their role in body burdens, species sensitivity, QSARs, and mixture effects. , 2002, Environmental science & technology.

[65]  John P. Giesy,et al.  Derivation and application of relative potency estimates based on in vitro bioassay results , 2000 .

[66]  K. Skegg,et al.  Is there seasonal variation in the prescribing of antidepressants in the community? , 1986, Journal of epidemiology and community health.

[67]  S. Hansen,et al.  Environmentally relevant concentrations of citalopram partially inhibit feeding in the three-spine stickleback (Gasterosteus aculeatus). , 2015, Aquatic toxicology.

[68]  D. Barceló,et al.  Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. , 2010, Environment international.

[69]  M. I C H A E,et al.  Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999-2000: A National Reconnaissance , 2002 .